APPROACHES FOR CONTROLLING INFECTION BY GENE THERAPY
APPROACHES FOR CONTROLLING INFECTION BY GENE THERAPY
批准号:
10044299
负责人:
ASANO Yoshihiro
金额:
$4.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
Th2细胞的成功发育需要分化和扩增两个过程,并依赖于IL-4受体(IL-4R)介导的信号的激活水平。在IL-4R下游的信号分子中,STAT6的激活被认为是分化过程中的关键,而IRS-2的磷酸化对细胞增殖是重要的。RAS/MAPK信号通路的激活可能作用于JAK1激酶,增强其活性,改善IL-4R功能。幼稚CD4T细胞中CN的激活诱导JAK3转录上调。在抗TCR激活的幼稚T细胞和已建立的克隆化Th2细胞中,Stat5被发现与IL-4受体复合体具有物理和功能上的相关性。IL-4诱导的STAT5激活似乎在发育中的Th2细胞的扩增过程中起着重要作用。因此,在发育中的Th2细胞中,JAK3和STAT5分子在功能IL-4R复合体中的募集似乎对Th2细胞的发育至关重要。我们证明了与沙门氏菌感染相关的脾肿大是一种宿主防御反应,是由Mac-1^+细胞迁移到感染的脾中引起的。我们试图用编码SV40早期抗原的无辅助子和复制缺陷的重组逆转录病毒来建立小鼠骨髓来源的DC株,并获得了几个可以独立生长的DC株。我们建立了单核细胞增生性李斯特菌突变株,当毒力基因激活时表达ply118基因产物。我们试图利用该突变李斯特菌建立基因转导系统。
英文摘要
Successful development of Th2 cells requires both differentiation and expansion processes, and depends on the activation levels of IL-4 receptor (IL-4R) -mediated signaling. Among signaling molecules downstream of IL-4R, STAT6 activation is thought to be critical for differentiation process, and phosphorylation of IRS-2 is important for proliferation. The activation of Ras/MAPK cascade appears to act on Jak1 kinase to enhance its kinase activity and improve IL-4R function. The activation of CN in naive CD4 T cells induces transcriptional upregulation of Jak3. STAT5 is found to be physically and functionally associated with IL-4 receptor complex in the anti-TCR-activated naive T cells and established cloned Th2 cells. The IL-4-induced activation of STAT5 appears to play an important role in the expansion process of the developing Th2 cells. Thus, the recruitment of Jak3 and STAT5 molecules to functional IL-4R complex in developing Th2 cells appears to be crucial for Th2 cell development.We demonstrated that the splenomegaly associated with Salmonella-infection, a host-defensive response, was caused by the migration of Mac-1^+ cells into the infected spleen. We tried to generate murine bone marrow-derived DC lines by using a helper-free and replication-defective recombinant retrovirus encoding the SV40 early antigens, and obtained several DC lines that can cytokine-independently grow.We established the mutant Listeria monocytogenes which expressed ply118 gene product when virulence genes are activated. We tried to establish the gene transduction system using this mutant Listeria.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Feng, C., S. Watanabe, S. Maruyama, G. Suzuki, M. Sato, T. Furuta, S. Kojima, S. Taki, and Y. Asano: "An alternate pathway for type 1 T cell differentiation"Int.Immunol.. 11. 1185-1194 (1999)
Feng, C.、S. Watanabe、S. Maruyama、G. Suzuki、M. Sato、T. Furuta、S. Kojima、S. Taki 和 Y. Asano:“1 型 T 细胞分化的替代途径”Int
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
浅野喜博: "自然免疫系と獲得免疫系の接点"愛媛医学. 18. 507-515 (1999)
浅野义宏:“先天性免疫系统和后天性免疫系统之间的接口”爱媛医学科学 18. 507-515 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tan, R.S-P., A.U.Kara, C.Feng, and Y.Asano: "Nitoric oxide is not essential in the protection of Plasmodium berghei blood stage murine malaria infection in IRF-1 (interferon regulatory factor-1) deficient mice."9th International Congress of Parasitology,
Tan、R.S-P.、A.U.Kara、C.Feng 和 Y.Asano:“一氧化氮对于保护 IRF-1(干扰素调节因子 1)缺陷小鼠的伯氏疟原虫血期鼠疟疾感染并不是必需的。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tan,R.S-P.: "Altered immune response of interferon regulatory factor-1 deficient (IRF-1-/-)mice against Plasmodium berghei blood stage malar"Infect.Immunity. 67. 2277-2283 (1999)
Tan,R.S-P.:“干扰素调节因子-1 缺陷 (IRF-1-/-) 小鼠对伯氏疟原虫血期颧骨的免疫反应发生改变”感染。免疫。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tan,R.S-P.: "Altered immune response of interferon regulatory factor-1 deficient(IRF-1-/-)mice against Plasmodium terghet blood stane malaria lafection" Infect.Immunity(印刷中).
Tan, R.S-P.:“干扰素调节因子-1 缺陷 (IRF-1-/-) 小鼠对疟原虫血样疟疾感染的免疫反应发生改变” Infect.Immunity(正在印刷中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Elucidation of the irreversible mechanism of severe heart failure using biological monitoring murine heart failure model
-
批准号:15K09139
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:ASANO Yoshihiro
-
依托单位:
A novel function of Interferon regulatory factor-1
-
批准号:24659475
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:ASANO Yoshihiro
-
依托单位:
Development of nursing process engine based on nursing data mapping
-
批准号:21592679
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:ASANO Yoshihiro
-
依托单位:
A Study for Epigenetic Regulation to Maintain Cardiac Homeostasis
-
批准号:21689022
-
项目类别:Grant-in-Aid for Young Scientists (A)
-
资助金额:$11.15万
-
财政年份:2009
-
负责人:ASANO Yoshihiro
-
依托单位:
Linkage between innate immunity and adaptive immunity during pahogen infection
-
批准号:14207012
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$24.88万
-
财政年份:2002
-
负责人:ASANO Yoshihiro
-
依托单位:
The 2nd pathway of T cell subset differentiation induced by pathogenic infection
-
批准号:10470086
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.52万
-
财政年份:1998
-
负责人:ASANO Yoshihiro
-
依托单位:
MOLECULAR MECHANISM OF THE THIRD TYPE OF CELL DEATH AND ITS APPLICATION FOR SPECIFIC IMMUNOSUPPRESSIVE THERAPY
-
批准号:09557048
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.68万
-
财政年份:1997
-
负责人:ASANO Yoshihiro
-
依托单位:
DEVELOPMENT OF MATERIALS WHICH HAVE INHIBITORY ACTIVITY ON GRAFT-VERSUS-HOST DISEASE ACCOPANIED BY BONE MARROW TRANSPLANTATION
-
批准号:05557032
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$6.21万
-
财政年份:1993
-
负责人:ASANO Yoshihiro
-
依托单位:
Analysis of mediators which regulate T-T cell interactions involved in regulatory immune responses.
-
批准号:01480187
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.29万
-
财政年份:1989
-
负责人:ASANO Yoshihiro
-
依托单位:
Analysis of adaptive expression of a T cell self-recognizing structure in radiation bone marrow chimeras.
-
批准号:61480155
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.16万
-
财政年份:1986
-
负责人:ASANO Yoshihiro
-
依托单位:
海外基金